Conavi Medical Inc., a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand the presence of its Novasight Hybrid System in the U.S. market in 2022 under ...
Optical Coherence Tomography (OCT)
Optical coherence tomography (OCT) is an catheter-based intravascular imaging technology that uses low-coherence light interferometry, using near-infrared light, to capture high-resolution 2-D and 3-D image reconstructions of coronary arteries. It has a lower level of tissue penetration than intravascular ultrasound (IVUS), but offers much higher resolution images of the tissues. It is used to determine the nature and extent of the atheroscleratic disease in the vessel wall, to assess in-stent restenosis and aid catheter procedure navigation in the cath lab.
-
-
December 15, 2021 — Conavi Medical Inc. has entered into agreements for over $20 million in funding to support commercialization and growth as it prepares its innovative Novasight Hybrid System for ...
-
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software. It ...
-
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical ...
August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding ...
August 29, 2023
August 29, 2023 — Abbott announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) ...
August 29, 2023
Conavi Medical Inc., a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand ...
February 16, 2022
December 15, 2021 — Conavi Medical Inc. has entered into agreements for over $20 million in funding to support ...
December 15, 2021
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence ...
August 05, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has ...
May 12, 2021
February 16, 2021 – SpectraWave Inc. announced a $13.2 million series A-2 financing to support completion of product ...
February 16, 2021
November 17, 2020 — Diagnostic imaging techniques were able to find the underlying cause of heart attack in many women ...
November 17, 2020
Feature | FFR Technologies | Dave Fornell, Editor
Fractional flow reserve (FFR) is considered the gold standard measure whether a coronary lesions needs a percutaneous ...
October 30, 2020
October 18, 2020 – Data from the COMBINE (OCT-FFR) study found that the use of FFR combined with OCT imaging can help ...
October 18, 2020
October 1, 2020 — A team of researchers led by the University of Adelaide and University of Stuttgart has used 3-D micro ...
October 01, 2020
Feature | Optical Coherence Tomography (OCT) | Aziz Maksoud M.D., FACC, FSCAI, and Bassem Chehab, M.D., FACC, FSCAI
Although not a new technology, optical coherence tomography (OCT) is the dark horse of imaging that could give ...
September 17, 2020
September 14, 2020 — Avinger received U.S. Food and Drug Administration (FDA) 510(k) clearance from the FDA for its ...
September 14, 2020
Nick West, M.D., chief medical officer for Abbott, explains the details from a survey of 1,400 patients, physicians and ...
September 14, 2020
June 26, 2020 — Abbott announced new data from the company's LightLab Initiative that showed optical coherence ...
June 26, 2020